Psychotropics India

PIL is emerging as one of the fastest growing pharmaceutical company in India, offering high quality products and services. The company has a CAGR of 25% for the last 5 years. With 800 plus highly motivated and skilled employees and a world class manufacturing infrastructure with four WHO GMP approved plants, the company is poised to establish itself as one of the top Indian pharma company. PIL has been focused in creating a risk-balanced and carefully diversified portfolio of products ranging from chronic diseasesegments like diabetes, neuropsychiatry, dermatologicals, pain management, anti infective, nutritionals, pet care products, affordable generics and strategic contract manufacturing to an attractive OTC/FMCG product range. This has been a key growth driver and has helped in establishing a good brand equity for PIL. The company is committed to investing in high quality manufacturing infrastructure and systems in delivering quality products to the market. PIL recently commissioned its fourth state of the art manufacturing facility for liquid injectable and dry powder cephalosporin at SIDCUL, Haridwar, India. The parenterals facility has independent lines for dry powders, vials & injectables. With a total of three manufacturing facilities at SIDCUL, Haridwar and one at Faridabad, near Delhi, these facilities enhance PIL’s manufacturing capabilities in solid oral dosages, sustained release dosages, liquid orals, with difficult to handle low Rh manufacturing zones, liquid and dry injectable products and dedicated zones to manufacture cephalosporin drug products and medicated soaps.These investments have already started giving results in the Generic Division. With more than 450 products at affordable prices & top quality, PIL’s Generic business especially in Rural markets is virtually growing at more than 35% YOY.